宋文瑋主治醫師
《現職》
中山醫學大學附設醫院
●泌尿科主治醫師
●人體生物資料庫管理中心主任
《專長》
泌尿系統腫瘤、攝護腺肥大、腎結石、泌尿道感染
《聯繫方式》
聯繫電話：04-24739595#34803
聯繫信箱：flutewayne@gmail.com
| 近五年論文著作 |
| 《2024》 1. Chen TY, Chang YC, Yu CY, Sung WW. Targeting the Adenosine A2A Receptor as a Novel Therapeutic Approach for Renal Cell Carcinoma: Mechanisms and Clinical Trial Review. Pharmaceutics. 2024, 16(9), 1127. (*corresponding author) 2. Sung MT, Huang HE, Chang YC, Yu CY, Luo HL*, Sung WW*. Anticancer Potential of Isoalantolactone in Testicular Cancer: An Analysis of Cytotoxicity, Apoptosis, and Signaling Pathways. Aging (Albany NY). (accepted) (*corresponding author) 3. Chang YC, Yu CY, Dong C, Chen SL, Sung WW*. Divergent histopathological and molecular patterns in chemically induced interstitial cystitis/bladder pain syndrome rat models. Sci Rep. 2024 Jul 12;14(1):16134. (*corresponding author) 4. Luan YZ, Wang CC, Yu CY, Chang YC, Sung WW*, Tsai MC*. The Therapeutic Role of NPS-1034 in Pancreatic Ductal Adenocarcinoma as Monotherapy and in Combination with Chemotherapy. Int. J. Mol. Sci. 2024 Jun, 25(13), 6919. (*corresponding author) 5. Yeh PS, Liu CT, Yu CY, Chang YC, Lin SY, Li YC, Luan YZ*, Sung WW*. Crebanine, an aporphine alkaloid, induces cancer cell apoptosis through PI3K-Akt pathway in glioblastoma multiforme. Front Pharmacol. 2024 Jun 04, 15:1419044. (*corresponding author) 6. Wu MY, Luo HL, Chang YC, Yu CY, Sung WW*. Exercise may improve lung immunity after surgical stress: evidence from a nephrectomy model via a bioinformatic analysis. PLoS One. 2024 Jun 7;19(6):e0303334. (*corresponding author) 7. Yang TH, Chang YC, Yu CY, Sung WW*, Lee TH* Correlation Between CT Density, Incidence, Mortality, and Mortality-to-Incidence Ratio in Central Nervous System Cancers: An Exploratory Analysis of Global Data. In Vivo. 2024 Jul-Aug;38(4):2024-2030. (*corresponding author) 8. Chang NW, Huang YH, Sung WW, Chen SL. Adjuvant Chemotherapy in Patients with Locally Advanced Upper Tract Urothelial Carcinoma with or without Kidney Transplantation. J Clin Med. 2024 Mar 22;13(7):1831. 9. Shih CH, Lin YH, Luo HL, Sung WW*. Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma. Front Pharmacol. 2024 Mar 20;15:1326296. (*corresponding author) 10. Wang CC, Huang JY, Weng LH, Hsu YC, Sung WW, Huang CY, Lin CC, Wei JC, Tsai MC. Association between Cholecystectomy and the Incidence of Pancreaticobiliary Cancer after Endoscopic Choledocholithiasis Management. Cancers (Basel). 2024 Feb 28;16(5):977. 《2023》 11. Tsai MC, Yen HH, Tsai HY, Huang YK, Luo YS, Kornelius E, Sung WW, Lin CC, Tseng MH, Wang CC. Artificial intelligence system for the detection of Barrett’s esophagus. World J Gastroenterol. 2023 Dec 28;29(48):6198-6207. 12. Wang SC, Hsu HC, Chang YC, Yu CY, Liu CT, Sung WW*. Melatonin Exhibits Partial Protective Effects against Gemcitabine- and Cisplatin-Induced Kidney and Reproductive Injuries in Mice. Aging (Albany NY). 2023 Dec 14;15(23):14372-14383. (*corresponding author) 13. Sung WW*. Re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023 Sep 5:S2588-9311(23)00171-2. (*corresponding author) 14. Chien TL, Wu YC, Lee HL, Sung WW, Yu CY, Chang YC, Lin CC, Wang CC, Tsai MC. PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic Cancer. Medicina (Kaunas). 2023 Aug 24;59(9):1531. 15. Dong C, Sung WW*. Characterization of Gender Differences in H-index Within Urological Subspecialties. Letter. J Urol. 2023 Oct;210(4):585. (*corresponding author) 16. Peng CK, Wang SC, Chen SL*, Sung WW*. Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance. Letter. J Urol. 2023 Oct;210(4):580-581. (*corresponding author) 17. Hsiao PR, Sung WW*. Re: Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA. Eur Urol. 2023 Jul;84(1):117-126. Eur Urol. 2023 Jul 22:S0302-2838(23)02970-6. (*corresponding author) 18. Peng CK, Sung WW*. Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses. J Urol. 2023 Sep;210(3):408-409. (*corresponding author) 19. Ho CJ, Huang YH, Hsieh TY, Yang MH, Wang SC, Chen WJ, Sung WW, Chen SL. New Hydronephrosis in the Native Kidney Is Associated with the Development of De Novo Urinary Bladder Urothelial Carcinoma in Patients with Post-Kidney Transplantation. Healthcare (Basel). 2023 Apr 23;11(9):1209. 20. Lu XP, Sung WW, Weng JH, Weng JH, Hsia JY, Kao PF. Bladder Distention Demonstrating Vesicourachal Diverticulum on 18 F-FDG PET/CT Images of a Lung Cancer Patient. Clin Nucl Med. 2023 Jul 1;48(7):610-611. 21. Hsieh TY#, Sung WW#, Chang YC, Yu CY, Lu LY, Dong C, Lee TH, Chen SL. Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma. Aging (Albany NY) (IF: 5.68; Q2). 2023 Apr 21;15. (#equal contribution) 22. Peng CK, Sung WW*, Chen SL*. Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study. Letter. J Urol. 2023 Mar 9. (*corresponding author) 23. Wang YT, Chen BS, Wu HR, Chang YC, Yu CY, Sung WW*. Favorable Mortality-to-Incidence Ratio Trends of Lung Cancer in Countries with High Computed Tomography Density. Medicina (Kaunas). 2023 Feb 9;59(2):322. (*corresponding author) 24. Chen KY, Chen SL, Sung WW*. Re: Yosuke Yasuda, J.J.H. Zhang, Worapat Attawettayanon, et al. Comprehensive Management of Renal Masses in Solitary Kidneys. Eur Urol Oncol. 2023 Feb 16. (*corresponding author) 25. Peng CK, Sung WW*. Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification. Letter. J Urol. 2023 Apr;209(4):676-677. (*corresponding author) 26. Su CC, Chen BS, Chen HH, Sung WW, Wang CC, Tsai MC. Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures. Healthcare (Basel). 2023 Jan 4;11(2):159. 27. Wang CC, Su CC, Huang YP, Huang WH, Tsai TY, Sung WW, Yang TW, Lin JT, Lin CC, Yen HH, Tsai MC. Subsequent Cholecystectomy Improve Recurrent Biliary Event-Free Survival in High-Risk Acute Cholecystitis Patients after Gallbladder Drainage. Adv Dig Med. 2023; 1-8. 28. Chen KY, Wang SC, Chen SL, Sung WW*. A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results From the Canadian Kidney Cancer Information System. Letter. J Urol. 2023 Apr;209(4):675. (*corresponding author) 《2022》 29. Dong C, Fu JT, Wu HR, Chao YC, Chen YC, Sung WW, Chen WJ, Chen CJ. Mortality-to-Incidence Ratio for Nasopharyngeal Carcinoma Is Associated with Health Expenditure. Healthcare (Basel). 2022 Aug 25;10(9):1615. 30. Peng CK, Tsao CH, Sung WW, Wang SC, Chen WJ, Hsieh TY, Yang MH, Lee TH, Chen SL. The Impact of Transoral Robotic Surgery on Erectile Dysfunction and Lower Urinary Tract Symptoms in Male Patients with Moderate-to-Severe Obstructive Sleep Apnea. Healthcare (Basel). 2022 Aug 26;10(9):1633. 31. Wu MY, Wang CC, Chang YC, Yu CY, Sung WW, Chen CJ, Tsai MC. The Therapeutic Role of PNU-74654 in Hepatocellular Carcinoma May Involve Suppression of NF-κB Signaling. Medicina 2022 Jun 14;58(6):798. 32. Chen WJ#, Sung WW#, Yu CY, Luan YZ, Chang YC, Chen SL, Lee TH. PNU-74654 Suppresses TNFR1/IKB Alpha/p65 Signaling and Induces Cell Death in Testicular Cancer. Curr. Issues Mol. Biol. 2022, 44(1), 222-232. (#equal contribution) 33. Yen YA, Wang CC, Sung WW, Fang KC, Huang SM, Lin CC, Tsai MC, Yang TW. Intragastric injection of botulinum toxin A for weight loss: A systematic review and meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2022 Apr 5. 2022 Jun;37(6):983-992. 34. Chen JT, Wang SC, Chen BS, Chang YC, Yu CY, Sung WW*, Song TY*. NPS-1034 Induce Cell Death with Suppression of TNFR1/NF-κB Signaling in Testicular Cancer. Medicina (Kaunas). 2022 Feb 27;58(3):355. (*corresponding author) 35. Dong C, Chen SL, Sung WW*. Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-293. Eur Urol. 2022 May;81(5):e123. (*corresponding author) 36. Wang SC, Yu CY, Wu YC, Chang YC, Chen SL, Sung WW*. Chidamide and mitomycin C exert synergistic cytotoxic effects against bladder cancer cells in vitro and suppress tumor growth in a rat bladder cancer model. Cancer Lett. 2022 Apr 1;530:8-15. (*corresponding author) 37. Yang TW, Wang CC, Sung WW, Ting WC, Lin CC, Tsai MC. The effect of coffee/caffeine on postoperative ileus following elective colorectal surgery: a meta-analysis of randomized controlled trials. Int J Colorectal Dis. 2022 Mar;37(3):623-630. 《2021》 38. Wang CC, Sung WW, Yan PY, Ko PY, Tsai MC. Favorable colorectal cancer mortality-to-incidence ratios in countries with high expenditures on health and development index: A study based on GLOBOCAN database. Medicine (Baltimore). 2021 Oct 15;100(41):e27414. 39. Ho CJ, Huang YH, Hsieh TY, Yang MH, Wang SC, Chen WJ, Lee TH, Sung WW, Chen SL. Native Kidney Hydronephrosis Is Associated with Upper Urinary Tract Urothelial Carcinoma in Post-Kidney Transplantation Patients. J Clin Med. 2021 Sep 28;10(19):4474. 40. Wang SC, Chang YC, Wu MY, Yu CY, Chen SL, Sung WW*. Intravesical instillation of azacitidine suppresses tumor formation through TNF-R1 and TRAIL-R2 signaling in genotoxic carcinogen-induced bladder cancer. Cancers (Basel). 2021 Aug 4;13(16):3933. (*corresponding author) 41. Yang TW, Wang CC, Hung WC, Liu YH, Sung WW, Tsai MC. Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures. Front Public Health. 2021 Aug 17;9:713895. 42. Sung WW#, Hsu YC#, Dong C, Chen YC, Chao YC, Chen CJ. Favorable Lip and Oral Cancer Mortality-to-Incidence Ratios in Countries with High Human Development Index and Expenditures on Health. Int J Environ Res Public Health. 2021 Jun 3;18(11):6012. (#equal contribution) 43. Lin KY, Su TC, Yeh CM, Chao WR, Sung WW*. High Expression of MTA1 Predicts Unfavorable Survival in Patients With Oral Squamous Cell Carcinoma. In Vivo. 2021 Jul-Aug;35(4):2363-2368. (*corresponding author) 44. Sung WW#, Au KK#, Wu HR, Yu CY, Wang YC. Improved trends of lung cancer mortality-to-incidence ratios in countries with high healthcare expenditure. Thorac Cancer. 2021 Jun;12(11):1656-1661. (#equal contribution) 45. Wu MY, Yang MH, Sung WW*. The treatment of renal cell carcinoma with the c-met inhibitor cabozantinib: mechanisms and clinical trials. Int J Clin Exp Med 2021 May;14(5):1831-1842. (*corresponding author) 46. Chia KJ, Lin LH, Sung MT, Su TM, Huang JF, Lee HL, Sung WW, Lee TH. Acute spontaneous thoracic epidural hematoma associated with intraspinal lymphangioma: A case report. World J Clin Cases. 2021 May 16;9(14):3411-3417. 47. Wang CC, Tseng MH, Wu SW, Yang TW, Chen HY, Sung WW, Su CC, Wang YT, Chen WL, Lai HC, Lin CC, Tsai MC. Symptomatic cholelithiasis patients have an increased risk of pancreatic cancer: A population-based study. J Gastroenterol Hepatol. 2021 May;36(5):1187-1196. 48. Yu WN, Lin HF, Lee YI, Shia WC, Sung WW, Yeh CM, Lin YM. PBK Expression Is Associated with Prognosis of Patients with Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study. Anticancer Res. 2021 Apr;41(4):2177-2182. 49. Lan C, Sung WW, Ho SW. Man With Fever and Groin Mass. Ann Emerg Med. 2021 Apr;77(4):e93-e94. 50. Wang CC, Tseng MH, Wu SW, Yang TW, Sung WW, Wang YT, Lee HL, Shiu BH, Lin CC, Tsai MC. The Role of Series Cholecystectomy in High Risk Acute Cholecystitis Patients Who Underwent Gallbladder Drainage. Front Surg. 2021 Feb 15;8:630916. 51. Huang CY, Wang SC, Chan L, Hsieh TY, Sung WW*, Chen SL*. Gender differences in trends of bladder cancer mortality-to-incidence ratios according to health expenditure in 55 countries. PLoS One. 2021 Feb 12;16(2): e0244510. (*corresponding author) 52. Wang SC, Chang NW, Chen WJ, Yang MH, Chen SL*, Sung WW*. Trends of Testicular Cancer Mortality-to-Incidence Ratios in Relation to Health Expenditure: An Ecological Study of 54 Countries. Int J Environ Res Public Health. 2021 Feb 6;18(4):1546. (*corresponding author) 53. Sung WW, Ko PY, Chen WJ, Wang SC, Chen SL. Trends in the kidney cancer mortality-to-incidence ratios according to health care expenditures of 56 countries. Sci Rep. 2021 Jan 14;11(1):1479. 54. Huang RH, Yang WK, Wu CM, Yeh CM, Sung WW*. Over-expression of CEP55 Predicts Favorable Prognosis in Colorectal Cancer Patients with Lymph Node Involvement. Anticancer Research 2021; 41 (1): 543-547. (*corresponding author) 《2020》 55. Yeh CM, Lee YJ, Ko PY, Lin YM*, Sung WW*. High Expression of KLF10 Is Associated with Favorable Survival in Patients with Oral Squamous Cell Carcinoma. Medicina (Kaunas). 2020 Dec 28;57(1):E17. (*corresponding author) 56. Wang CC, Tseng MH, Wu SW, Yang TW, Chen HY, Sung WW, Su CC, Wang YT, Lin CC, Tsai MC. Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention. World J Gastrointest Oncol. 2020 Dec 15;12(12):1381-1393. 57. Wang SC, Chan L, Hsieh ZY, Wang CH, Chen SL, Sung WW*. Limited improvement in prostate cancer mortality-to-incidence ratios in countries with high health care expenditures. Aging (Albany NY). 2020 Nov 12;12(21):21308-21315. (*corresponding author) 58. Lin YM, Chen ML, Chen CL, Yeh CM, Sung WW*. Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. Diagnostics (Basel). 2020 Jun 27;10(7):E436. (*corresponding author) 59. Wang CC, Yang TW, Sung WW, Tsai MC. Current Endoscopic Management of Malignant Biliary Stricture. Medicina (Kaunas). 2020 Mar 5;56(3). pii: E114. 60. Lee YJ, Chan L, Yeh CM, Lee CH*, Sung WW*. Overexpression of KLF17 Predicts a Favorable Prognosis in Patients with Oral Squamous Cell Carcinoma: A Retrospective Study. Medicina (Kaunas). 2020 Jan 30;56(2). pii: E57. (*corresponding author) 《2019》 61. Chen WJ, Huang CY, Huang YH, Wang SC, Hsieh TY, Chen SL, Sung WW*, Lee TH*. Correlations between Mortality-to-Incidence Ratios and Health Care Disparities in Testicular Cancer. Int J Environ Res Public Health. 2019 Dec 23;17(1). pii: E130. (*equal contribution) 62. Yang TH, Chang CS, Sung WW, Liu JT. Lumboperitoneal Shunt: A New Modified Surgical Technique and a Comparison of the Complications with Ventriculoperitoneal Shunt in a Single Center. Medicina (Kaunas). 2019 Sep 26;55(10). pii: E643. 63. Lee TH#, Sung WW#, Chan L, Lee HL, Chen SL, Huang YH, Kwan AL. The Association between Mortality-to-Incidence Ratios and Health Expenditures in Brain and Nervous System Cancers. Int J Environ Res Public Health. 2019 Jul 31;16(15). pii: E2739. (#equal contribution) 64. Wang CC, Tsai MC, Wang SC, Peng CM, Lee HL, Chen HY, Yang TW, Lin CC*, Sung WW*. Favorable Gallbladder Cancer Mortality-To-Incidence Ratios of Countries with Good Ranking of World’s Health System and High Expenditures on Health. BMC Public Health. 2019 Jul 31;19(1):1025. (*corresponding author) 65. Chen ML, Ho CJ, Yeh CM, Sung WW, Chen SL, Wang SC, Chen CJ. High SPOCK1 expression is associated with advanced stage, T value, and Gleason grade in prostate cancer. Medicina. 2019 Jul 5;55(7). pii: E343. 66. Lee TH, Huang YH, Su TM, Chen CF, Lu CH, Lee HL, Tsai HP, Sung WW*, Kwan AL*. Predictive Factors of 2-Year Postoperative Outcomes in Patients with Spontaneous Cerebellar Hemorrhage. J Clin Med. 2019 Jun 8;8(6). pii: E818. (*corresponding author) 67. Wang CC, Tsai MC, Sung WW, Yang TW, Chen HY, Wang YT, Su CC, Tseng MH, Lin CC. Risk of cholangiocarcinoma in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography or cholecystectomy: A population based study. World J Gastrointest Oncol. Mar 15, 2019; 11(3): 238-249. 68. Wang CC, Tsai MC, Wang YT, Yang TW, Chen HY, Sung WW, Huang SM, Tseng MH, Lin CC. Role of Cholecystectomy in Choledocholithiasis Patients Underwent Endoscopic Retrograde Cholangiopancreatography. Sci Rep. 2019 Feb 18;9(1):2168. |